AnaptysBio
ANAB
#5383
Rank
โ‚ฌ1.39 B
Marketcap
46,98ย โ‚ฌ
Share price
-0.22%
Change (1 day)
110.75%
Change (1 year)

Revenue for AnaptysBio (ANAB)

Revenue in 2026 (TTM): โ‚ฌ0.19 Billion

According to AnaptysBio's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.20 Billion. In 2025 the company made a revenue of โ‚ฌ0.19 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ87.71 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AnaptysBio from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.19 B-0.78%
2025 โ‚ฌ0.19 B127.67%
2024 โ‚ฌ87.71 M465.18%
2023 โ‚ฌ15.52 M61.84%
2022 โ‚ฌ9.59 M-82.81%
2021 โ‚ฌ55.78 M-8.52%
2020 โ‚ฌ60.97 M753.84%
2019 โ‚ฌ7.14 M63.39%
2018 โ‚ฌ4.37 M-47.56%
2017 โ‚ฌ8.33 M-47.46%
2016 โ‚ฌ15.86 M-1.3%
2015 โ‚ฌ16.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA